A Northwestern Medicine-led study published in the Journal of Clinical Investigation has uncovered why older individuals with ...

A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...

In 2026, the spotlight will be on a handful of therapeutic strategies that could change cancer care for patients by offering ...

Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid limited options. The FDA has granted orphan drug designation (ODD) to ARB1002, ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

CARY, NC, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- The CEO Roundtable on Cancer (CEORT) today announced ...